Biomerica, Inc. (BMRA) Obtains Approval to Market H. Pylori and PTH Tests in Mexico, Appoints New Mexico Distributor
Global biomedical company Biomerica announced it has been granted approval to market and sell its H. pylori and parathyroid hormone (PTH) diagnostic tests in Mexico. Biomerica has additionally announced the appointment of a new distributor in Mexico, which has more than 35 years of experience and 200 overall employees. Biomerica’s H. pylori test enables labs to automate testing for H. pylori quickly and cost-effectively. Helicobacter pylori (H. pylori) is a bacterium responsible for more than 85% of ulcers. The worldwide anti-ulcer market is estimated at more than $9.5 billion, and epidemiological studies have shown that the H. pylori infection is…